• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Oxygen Biotherapeutics, Inc. to Present at Investor Conferences in Zurich

Posted on: Tuesday, 22 September 2009, 07:30 CDT

DURHAM, N.C., Sept. 22 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) today announced that company chairman and CEO, Chris Stern, will present at an investor conferences in Zurich on Sept. 30, 2009.

The presentation will be at the Zurich Airport Radisson Hotel and is scheduled for 7:00 p.m. The German language presentation will not be webcast but will be open to interested investors.

About Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and Defense Medicine(TM). The company has under development a perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (Oxycyte((R))) and has out-licensed an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs as well as medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets including traumatic brain injury, sickle cell crisis, trauma, wound care, decompression sickness, acute respiratory distress syndrome, stroke, myocardial infarction, surgery, diabetes wounds and ulcers, and cosmetic applications. More information is available at www.oxybiomed.com.

SOURCE Oxygen Biotherapeutics, Inc.

Source: PR Newswire

More News in this Category